GnRH agonists vs antagonists

Best Practice & Research Clinical Obstetrics & Gynaecology - Tập 21 Số 1 - Trang 57-65 - 2007
Basil C. Tarlatzis1, Efstratios M. Κolibianakis
1Unit for Human Reproduction, 1st Department of Obstetrics and Gynaecology, Aristotle University of Thessaloniki, Thessaloniki, Greece. [email protected]

Tóm tắt

Từ khóa


Tài liệu tham khảo

Loumaye, 1990, The control of endogenous secretion of LH by gonadotrophin-releasing hormone agonists during ovarian hyperstimulation for in-vitro fertilization and embryo transfer, Hum Reprod, 5, 357, 10.1093/oxfordjournals.humrep.a137105

Lejeune, 1986, In vitro fertilization and embryo transfer as related to endogenous luteinizing hormone rise or human chorionic gonadotropin administration, Fertil Steril, 45, 377, 10.1016/S0015-0282(16)49220-4

Porter, 1984, Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins, Lancet, 2, 1284, 10.1016/S0140-6736(84)92840-X

Schally, 1971, Isolation and properties of the FSH and LH-releasing hormone, Biochem Biophys Res Commun, 43, 393, 10.1016/0006-291X(71)90766-2

Fujino, 1974, Some analogs of luteinizing hormone releasing hormone (LH-RH) having intense ovulation-inducing activity, Biochem Biophys Res Commun, 57, 1248, 10.1016/0006-291X(74)90830-4

Clayton, 1980, Receptor-binding affinity of gonadotropin-releasing hormone analogs: analysis by radioligand-receptor assay, Endocrinology, 106, 1154, 10.1210/endo-106-4-1154

Karten, 1986, Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: rationale and perspective, Endocr Rev, 7, 44, 10.1210/edrv-7-1-44

Reissmann, 1995, Development and applications of luteinizing hormone-releasing hormone antagonists in the treatment of infertility: an overview, Hum Reprod, 10, 1974, 10.1093/oxfordjournals.humrep.a136219

Kenigsberg, 1984, Medical hypophysectomy: I. Dose-response using a gonadotropin-releasing hormone antagonist, Fertil Steril, 42, 112, 10.1016/S0015-0282(16)47968-9

Felberbaum, 1995, Gynakol Geburtshilfliche Rundsch, 35, 113, 10.1159/000272579

Klingmuller, 1993, Hormonal responses to the new potent GnRH antagonist Cetrorelix, Acta Endocrinol (Copenh), 128, 15, 10.1530/acta.0.1280015

Kiesel, 1992, Gynakol Geburtshilfliche Rundsch, 32, 22, 10.1159/000271829

Hahn, 1985, Reproductive/endocrine and anaphylactoid properties of an LHRH-antagonist, ORF 18260, Life Sci, 37, 505, 10.1016/0024-3205(85)90462-X

Hughes, 1992, The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials, Fertil Steril, 58, 888, 10.1016/S0015-0282(16)55430-2

Smitz, 1992, Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol, Hum Reprod, 7, 1225, 10.1093/oxfordjournals.humrep.a137831

Forman, 1990, Severe ovarian hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for in vitro fertilization: a European series and a proposal for prevention, Fertil Steril, 53, 502, 10.1016/S0015-0282(16)53348-2

Daya, 2000, Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles, Cochrane Database Syst Rev, 2, CD001299

Ljungqvist, 1988, Antide and related antagonists of luteinizing hormone release with long action and oral activity, Proc Natl Acad Sci USA, 85, 8236, 10.1073/pnas.85.21.8236

Dubourdieu, 1991, Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration, Fertil Steril, 56, 440, 10.1016/S0015-0282(16)54537-3

Rabinovici, 1992, Endocrine effects and pharmacokinetic characteristics of a potent new gonadotropin-releasing hormone antagonist (Ganirelix) with minimal histamine-releasing properties: studies in postmenopausal women, J Clin Endocrinol Metab, 75, 1220, 10.1210/jc.75.5.1220

Duijkers, 1998, Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteers, Hum Reprod, 13, 2392, 10.1093/humrep/13.9.2392

Mannaerts, 2000, Embryo implantation and GnRH antagonists: GnRH antagonists do not activate the GnRH receptor, Hum Reprod, 15, 1882, 10.1093/humrep/15.9.1882

Leroy, 1994, A single injection of a gonadotropin-releasing hormone (GnRH) antagonist (Cetrorelix) postpones the luteinizing hormone (LH) surge: further evidence for the role of GnRH during the LH surge, Fertil Steril, 62, 461, 10.1016/S0015-0282(16)56932-5

Diedrich, 1994, Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation, Hum Reprod, 9, 788, 10.1093/oxfordjournals.humrep.a138597

Olivennes, 1994, The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization-embryo transfer program, Fertil Steril, 62, 468, 10.1016/S0015-0282(16)56933-7

Albano, 1997, Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation, Fertil Steril, 67, 917, 10.1016/S0015-0282(97)81407-0

1998, Hum Reprod, 13, 3023, 10.1093/humrep/13.11.3023

Olivennes, 1998, The use of a GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2mg, Hum Reprod, 13, 2411, 10.1093/humrep/13.9.2411

Fischl, 2001, Obruca a Zeitliche optimierung der kontrollierten hyperstimulation (koh) in kombination mit gnrh-antagonisten und ovulationshemmer in einem ivf-programm, Journal Für Fertilität Und Reproduktion, 11, 50

Kolibianakis, 2006, Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial, Hum Reprod, 21, 352, 10.1093/humrep/dei348

Rombauts, 2006, A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients, Hum Reprod, 21, 95, 10.1093/humrep/dei302

Griesinger, 2004, What is the most relevant standard of success in assisted reproduction? Is BESST (birth emphasizing a successful singleton at term) truly the best?, Hum Reprod, 19, 1239, 10.1093/humrep/deh237

Germond, 2004, What is the most relevant standard of success in assisted reproduction? The cumulated singleton/twin delivery rates per oocyte pick-up: the CUSIDERA and CUTWIDERA, Hum Reprod, 19, 2442, 10.1093/humrep/deh501

Heijnen, 2004, What is the most relevant standard of success in assisted reproduction? The next step to improving outcomes of IVF: consider the whole treatment, Hum Reprod, 19, 1936, 10.1093/humrep/deh368

Min, 2004, What is the most relevant standard of success in assisted reproduction? The singleton, term gestation, live birth rate per cycle initiated: the BESST endpoint for assisted reproduction, Hum Reprod, 19, 3, 10.1093/humrep/deh028

Tiitinen, 2004, What is the most relevant standard of success in assisted reproduction? The value of cryopreservation on cumulative pregnancy rates per single oocyte retrieval should not be forgotten, Hum Reprod, 19, 2439, 10.1093/humrep/deh446

Arce, 2005, Resolving methodological and clinical issues in the design of efficacy trials in assisted reproductive technologies: a mini-review, Hum Reprod, 20, 1757, 10.1093/humrep/deh818

Ludwig, 2001, Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis, Arch Gynecol Obstet, 265, 175, 10.1007/s00404-001-0267-2

Al-Inany, 2002, GnRH antagonist in assisted reproduction: a Cochrane review, Hum Reprod, 17, 874, 10.1093/humrep/17.4.874

Daya, 2003, A comparison of clinical pregnancy rates in the efficacy evaluation of GnRH agonist versus antagonist use for assisted reproduction – a meta-analysis using an intention to treat approach, Gynaecol Endocrinol, 17, 44

Kolibianakis EM, Collins J, Tarlatzis BC et al. Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update [in press].

Tarlatzis, 2006, GnRH antagonists in ovarian stimulation for IVF, Hum Reprod Update, 12, 333, 10.1093/humupd/dml001